Actinium Pharmaceuticals
ATNM
#9636
Rank
โ‚น3.40 B
Marketcap
โ‚น109.21
Share price
0.79%
Change (1 day)
-81.44%
Change (1 year)

Revenue for Actinium Pharmaceuticals (ATNM)

Revenue in 2024 (TTM): N/A

a decrease over the revenue in the year 2023 that were of โ‚น6.74 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Actinium Pharmaceuticals from 2007 to 2024

Annual revenue

Year Revenue Change
2024 N/A-100%
2023 โ‚น6.74 M-92.09%
2022 โ‚น85.23 M0.1%
2021 โ‚น85.14 M
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A
2012 N/A
2011 N/A
2010 N/A
2009 N/A
2008 N/A
2007 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น0.16 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น243.49 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น45.07 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA